ATP7A and ovarian carcinoma: Treatment with TF3 upregulated the protein levels of CTR1 in ovarian cancer A2780/CP70 and OVCAR3 cells, but had no significant effect on the protein levels of MRP2, ATP7A and ATP7B (p > 0.05).